Impax Settles Cephalon Suit Over Generic Amrix
Impax Laboratories Inc. has settled Cephalon Inc.'s lawsuit over its efforts to market a generic version of the prescription muscle relaxant Amrix, leaving Cephalon to wage parallel suits against other generic-drug...To view the full article, register now.
Already a subscriber? Click here to view full article